Sugary drinks associated with increased cancer risk

Much has been said about the impact of excessive consumption of sugary drinks on health and we know of its link to many metabolic diseases, but a new study associates sugary drinks at increased risk of cancer.

Study Data

The research, conducted by scientists at the University of Oxford, analyzed data from more than 70,000 adults for little more than 13 years to determine the link between intake of sugary drinks and the risk of developing gallbladder cancer.

Since the excess blood sugar that can be derived from the usual consumption of sugary drinks is associated with a higher body weight and a higher incidence of type 2 diabetes and these two factors are involved in the development of bile duct cancer, the study raises the hypothesis That the intake of sugary drinks could favor the development of this type of cancer.

Thus, it was concluded after discarding other risk factors that the consumption of more than two servings of sugary drinks daily are associated with a higher incidence of bile duct cancer, considering a serving as 200 ml of drink.

Two daily servings of sugary drinks, for example a soda, is equivalent to more than 35 grams of sugar, which is undoubtedly excessive for a regular diet of 2000 Kcal per day.

Just sugary drinks?

Although the study only links the consumption of sugary beverages to a higher incidence of bile duct cancer, excess sugar intake has been associated with a higher rate of cancer development, so we can assume that not only sugar drinks can cause More risk of degenerative diseases.

That is, anything that contains sugar and is consumed in large quantities may represent a risk to the body and be a potential cause of disease.

Also, the lifestyle that accompanies the increased consumption of sugar can be decisive in the development of cancer or other diseases associated with our habits.

Therefore, more than sugary drinks we should consider that an excess of sugar in our diet could be one more factor that increases the risk of cancer.